Thursday, January 10, 2008

"Priority review vouchers" would create incentives to develop drugs for neglected diseases

A paper by David Ridley, Henry Grabowski, and Jeffrey Moe (Duke) proposes that the FDA create "priority voucher reviews" for pharmaceutical companies that introduce drugs fo neglected or tropical diseases, as an alternative to extended patent life.


No comments: